| CAT No: | CL-TZMT-04 |
| CAS No: | 1403257-80-6 |
| Mol.F: | C23H30BrN3O3 |
| Mol.Wt.: | 476.4 |
| Rel. Cas No: | |
| Chemical Name: | 5-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-methylbenzamide |
| SMILES: | CCN(C1CCOCC1)c2cc(Br)cc(C(=O)NCC3=C(C)C=C(C)NC3=O)c2C |
| Inventory Status: | Custom synthesis |
This impurity is related to Tazemetostat Impurity 2 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Tazemetostat Impurity 2 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:5-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-methylbenzamideCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Tazemetostat Molecular Formula: C23H30BrN3O3
Molecular Weight: 476.4
Storage: Store in a cool, dry place.
| Product Name: | Tazemetostat Impurity 2 |
| CAS No: | 1403257-80-6 |
| Mol.F.: | C23H30BrN3O3 |
| Mol.Wt.: | 476.4 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: